Tuberculosis Study
-
{
- All
- News
- Videos
-
Gut Microbiome Changes In Parkinson's Risk Gene Carriers Could Help Predict Disease: Analysis
A study found that gut microbiome changes in carriers of the GBA1 gene variant may signal early Parkinsons disease development.
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
Overlooked And More Aggressive Parkinson's Variant Hits Indians Harder: Study Finds
A NIMHANS study warns that atypical Parkinsonism, an often-misdiagnosed variant, may progress faster and harm Indian patients more severely.
-
Ayurveda And AI Integration, Large-Scale Screening: Next Phase Of 100-Day TB Mukt Bharat Campaign Launched
Union Health Minister JP Nadda has launched the next phase of the 100-day TB Mukt Bharat campaign, targeting high-risk populations with intensified screening, early detection, and improved treatment access to accelerate India's TB elimination goals.
-
India Launches Clinical Study Integrating Traditional Ayurveda With Modern Tuberculosis Treatments
India on Tuesday launched a first-of-its-kind global clinical study to scientifically evaluate traditional Ayurveda as an adjunct to modern tuberculosis (TB) treatments.
-
6-Month Drug-Resistant Tuberculosis Treatment More Effective, Cheaper Than Existing Regimens: ICMR Study
The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of care.
-
Tuberculosis: Short 6-Month Oral Treatment Plan Proves Affordable In India
Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.
-
AI-Enabled Stethoscopes Show Promise In Improving Health Screenings
As tuberculosis (TB) continues as the deadliest infectious cause of deaths globally, a new study has shown that artificial intelligence (AI)-enabled digital stethoscopes can help fill critical screening gaps, especially in hard-to-reach areas.
-
Tuberculosis Bacteria Are Mutating, Turning Antibiotic Resistant: IIT Bombay Study
The bacteria Mycobacterium tuberculosis, which causes the world's most infectious disease Tuberculosis (TB), can survive antibiotic treatment and live longer by changing their outer fat coating, according to a new study.
-
Study By Indian Doctor Couple Inspires Major WHO Change In Tuberculosis Treatment And Care
The World Health Organization (WHO) has released revised guidelines on tuberculosis (TB) and undernutrition, introducing a novel recommendation rooted in evidence from India's landmark RATIONS trial.
-
Gut Microbiome Changes In Parkinson's Risk Gene Carriers Could Help Predict Disease: Analysis
A study found that gut microbiome changes in carriers of the GBA1 gene variant may signal early Parkinsons disease development.
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
Overlooked And More Aggressive Parkinson's Variant Hits Indians Harder: Study Finds
A NIMHANS study warns that atypical Parkinsonism, an often-misdiagnosed variant, may progress faster and harm Indian patients more severely.
-
Ayurveda And AI Integration, Large-Scale Screening: Next Phase Of 100-Day TB Mukt Bharat Campaign Launched
Union Health Minister JP Nadda has launched the next phase of the 100-day TB Mukt Bharat campaign, targeting high-risk populations with intensified screening, early detection, and improved treatment access to accelerate India's TB elimination goals.
-
India Launches Clinical Study Integrating Traditional Ayurveda With Modern Tuberculosis Treatments
India on Tuesday launched a first-of-its-kind global clinical study to scientifically evaluate traditional Ayurveda as an adjunct to modern tuberculosis (TB) treatments.
-
6-Month Drug-Resistant Tuberculosis Treatment More Effective, Cheaper Than Existing Regimens: ICMR Study
The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of care.
-
Tuberculosis: Short 6-Month Oral Treatment Plan Proves Affordable In India
Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.
-
AI-Enabled Stethoscopes Show Promise In Improving Health Screenings
As tuberculosis (TB) continues as the deadliest infectious cause of deaths globally, a new study has shown that artificial intelligence (AI)-enabled digital stethoscopes can help fill critical screening gaps, especially in hard-to-reach areas.
-
Tuberculosis Bacteria Are Mutating, Turning Antibiotic Resistant: IIT Bombay Study
The bacteria Mycobacterium tuberculosis, which causes the world's most infectious disease Tuberculosis (TB), can survive antibiotic treatment and live longer by changing their outer fat coating, according to a new study.
-
Study By Indian Doctor Couple Inspires Major WHO Change In Tuberculosis Treatment And Care
The World Health Organization (WHO) has released revised guidelines on tuberculosis (TB) and undernutrition, introducing a novel recommendation rooted in evidence from India's landmark RATIONS trial.
